Format

Send to

Choose Destination
Am J Hematol. 2017 Apr;92(4):E48-E51. doi: 10.1002/ajh.24657. Epub 2017 Feb 24.

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.

Author information

1
Oncohematology Division, IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, and Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
2
Division of Pathology, Department of Pathophysiology and Transplantation, University of Milan, and IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, Milan, Italy.
3
Institute of Pathology, University of Cologne, Cologne, Germany.
4
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York.
PMID:
28109016
DOI:
10.1002/ajh.24657
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center